Elevance Health Inc. stock underperforms Thursday when compared to competitors
Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.
Elevance Health (NYSE:ELV) Posts Q4 Sales In Line With Estimates
Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% ...
Hosted on MSN21d
Unveiling Elevance Health (ELV) Q4 Outlook: Wall Street Estimates for Key Metrics
Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $3.82 per share in its upcoming release, pointing to a year-over-year decline of 32%.
Elevance Health (NYSE:ELV) Upgraded at StockNews.com
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Elevance Health (ELV) and Genmab (GMAB)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Neurosense Therapeutics Ltd. (NRSN – Research Report), ...